http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108250162-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D301-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D301-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-40
filingDate 2017-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108250162-B
titleOfInvention Pharmaceutical intermediate diaryl oxirane compound and synthesis method thereof
abstract The invention relates to a diaryl oxirane compound as a medical intermediate shown in a formula (I) and a synthesis method thereof, wherein R is 1 Selected from H, halogen or C 1 ‑C 6 An alkyl group; r 2 Selected from H, halogen, C 1 ‑C 6 Alkyl radical, C 1 ‑C 6 Alkoxy, halo C 1 ‑C 6 Alkyl or halo C 1 ‑C 6 An alkoxy group. Also relates to a synthetic method of the derivative. The diaryl oxirane compound can be used for synthesizing isocoumarin compounds in one step, and thus has good application prospect and research value in the field of synthesis of isocoumarin compounds.
priorityDate 2017-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412224690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77068308
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456420185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408720137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23132015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5324280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415765522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447764437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451609708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450418934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449767235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8135
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50930385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450067302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154726000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411302047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68108

Total number of triples: 45.